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ABSTRACT 
 
NF-κB is a transcription factor activated in response to inflammatory, genotoxic and oxidative stress and 
important for driving senescence and aging.  Ataxia-telangiectasia mutated (ATM) kinase, a core component 
of DNA damage response signaling, activates NF-κB in response to genotoxic and oxidative stress via post-
translational modifications. Here we demonstrate that ATM is activated in senescent cells in culture and 
murine tissues from Ercc1-deficient mouse models of accelerated aging, as well as naturally aged mice. 
Genetic and pharmacologic inhibition of ATM reduced activation of NF-κB and markers of senescence and 
the senescence-associated secretory phenotype (SASP) in senescent Ercc1-/- MEFs. Ercc1-/Δ mice 
heterozygous for Atm have reduced NF-κB activity and cellular senescence, improved function of muscle-
derived stem/progenitor cells (MDSPCs) and extended healthspan with reduced age-related pathology 
especially age-related bone and intervertebral disc pathologies. In addition, treatment of Ercc1-/∆ mice with 
the ATM inhibitor KU-55933 suppressed markers of senescence and SASP.  Taken together, these results 
demonstrate that the ATM kinase is a major mediator of DNA damage-induced, NF-κB-mediated cellular 
senescence, stem cell dysfunction and aging and thus, represents a therapeutic target to slow the 
progression of aging. 
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INTRODUCTION 
 
With aging there is an inevitable and progressive loss of 
the ability of tissues to recover from stress, leading to the 
increased incidence of chronic degenerative diseases. The 
loss of tissue homeostasis is driven, in part, by an 
increase in cellular senescence and a decline in stem cell 
function, resulting in various aging-related diseases, 
including osteoporosis, intervertebral disc degeneration, 
chronic kidney disease, diabetes, neurodegeneration and 
cancer [1–5]. Cellular senescence, characterized by 
irreversible cell cycle arrest with sustained metabolic 
activity, is a biological process that is physiologically 
required during embryonic development, wound healing 
and tumor suppression [6–10]. Importantly, senescent 
cells can develop a senescence-associated secretory 
phenotype (SASP), including expression of IL-6, IL-1α, 
IL-1β and TNF-α, that affects neighboring cells, disrupts 
stem cell niches, alters extracellular matrix, and induces 
secondary senescence [8, 11, 12]. Cellular senescence is 
mediated by p53/p21 and p16INK4a/retinoblastoma (Rb) 
tumor suppressor pathways in response to stress [8, 13] 
conferred by telomere attrition, DNA damage, oxidative 
and inflammatory stress and oncogene dysregulation [8].  
 
Cellular senescence directly contributes to the 
progression of aging. For example, depletion of p16INK4a 
positive cells in both progeroid and naturally aged 
transgenic mice expressing an inducible apoptotic 
transgene from the p16INK4a promoter leads to an 
extension of healthspan [2, 3]. Similarly, clearance of 
senescent cells using senolytic agents extends 
healthspan, improves adult stem cell function and 
extends lifespan in mice [4, 5, 14–17].  
 
The DNA damage response (DDR), essential for 
genome stability and organismal survival [18–21], is 
mediated through pathways that recruit multi-protein 
complexes to sites of DNA double-strand breaks 
(DSBs) or stalled replication forks. In particular, the 
MRE11-RAD50-NBS1 (MRN) complex is recruited to 
sites of DSBs to facilitate the recruitment, retention and 
activation of the ataxia-telangiectasia mutated (ATM) 
kinase [22]. Autophosphorylation of ATM at Ser1981 
enhances its kinase activity, leading to phosphorylation 
of histone H2A variant H2AX (γH2AX) in nucleosomes 
surrounding damaged sites and recruiting more ATM 
and other repair factors [22, 23]. Additional DDR 
proteins, including KRAB-associated protein-1 (KAP1), 
p53 and checkpoint kinase 2 (CHK2), are 
phosphorylated by ATM kinase, promoting DNA repair, 
cell-cycle arrest, apoptosis and/or senescence [24, 25].  
 
The Nuclear Factor κB (NF-κB) family of 
transcription factors consists of five members in 
mammalian cells, including RelA (p65), RelB, c-Rel, 
p50/p105 and p52/p100 [26]. All NF-κB subunits 
contain a Rel-homology domain (RHD), which is 
essential for DNA binding activity and dimerization. 
NF-κB functions to regulate innate and adaptive 
immune responses, embryonic development, 
proliferation, apoptosis, oncogenesis and senescence 
[26]. The canonical NF-κB pathway is activated by 
inflammatory stimuli, such as TNF-α, IL-1β and LPS, 
which lead to the activation of the IκB kinase (IKK). 
IKK is composed of two catalytic subunits, IKKα and 
IKKβ, and one regulatory subunit, NF-κB essential 
modifier (NEMO) or IKKγ [26]. Activated IKK 
complex phosphorylates the inhibitory protein IκBα to 
facilitate its polyubiquitination and degradation by the 
26S proteasome, resulting in the translocation of the 
NF-κB heterodimer into the nucleus where it regulates 
gene transcription [26]. In addition, genotoxic stress 
activates a TNF-α-independent, but ATM-dependent 
NF-κB pathway via nuclear-localized NEMO [27, 28]. 
ATM phosphorylates NEMO at Ser85, which in turn 
induces sumoylation and mono-ubiquitination of 
NEMO at Lys277 and 309 [29]. These post-
translational modifications eventually lead to the 
nuclear export of the ATM-NEMO complex to the 
cytoplasm where it associates with ubiquitin and 
SUMO-1 modified RIP1 and TAK1, activating the 
catalytic IKKβ subunit [28, 30].  
 
NF-κB activity increases in multiple tissues of humans 
and rodents with aging and promotes cellular senescence 
[31–36]. Genetic depletion of RelA/p65 in aged mouse 
skin and a mouse model of human progeroid syndrome, 
reversed gene expression signature of aging and aging 
phenotypes [35, 37]. In addition, heterozygosity of 
p65/RelA in a mouse model of Hutchinson-Gilford 
Progeria Syndrome (Zmpste24-/-) resulted in attenuated 
aging pathology and a prolonged lifespan, linked in part 
to a reduced systemic inflammatory response and a 
reduction in ATM/NEMO-mediated NF-κB activation 
[34]. In addition, Nfkb1-/- (p50-/-) mice have increased 
low-grade inflammation with signs of premature aging, 
including neural degeneration, impaired regeneration and 
declined overall lifespan [38–41]. Activation of NF-κB 
also is associated with multiple aging-related chronic 
diseases, including Alzheimer’s disease, Parkinson’s 
disease, Type II diabetes, osteoporosis and 
atherosclerosis [42], possibly through an increase in 
secretion of SASP factors [43]. 
 
DNA damage is known to increase with aging as 
demonstrated by an increase in DNA damage foci 
(γH2AX) and oxidative DNA lesions (8,5’-
cyclopurines) [44, 45]. Intriguingly, persistent DDR 
signaling mediated by ATM activation has been 
reported to contribute to cellular senescence and SASP 
[46]. In vitro, SASP is dependent on ATM activation, 
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suggesting a molecular link between ATM and NF-κB 
[8, 46, 47]. However, it is still unclear if aberrant DNA 
damage-induced activation of ATM in vivo exacerbates 
the cellular stress response to increase NF-κB, 
senescence, SASP and subsequently aging.  
 
To address the role of ATM in driving NF-κB mediated 
senescence and aging, we used Ercc1-/Δ mice that model a 
human progeroid syndrome caused by impaired repair of 
DNA damage. The mice express only 5% of the normal 
level of the DNA repair endonuclease ERCC1-XPF that is 
required for nucleotide excision, interstrand crosslink and 
repair of some double-strand breaks. As a consequence, 
the Ercc1-/Δ mice spontaneously and rapidly develop 
progressive age-related diseases, including osteoporosis, 
sarcopenia, intervertebral disc degeneration, 
glomerulonephropathy, neurodegeneration, peripheral 
neuropathy and loss of cognition [48].  
 
Here, we demonstrate that ATM and downstream 
effectors are persistently elevated in Ercc1-/∆ and 
naturally aged mice, concomitant with hyperactive NF-
κB signaling. Reducing ATM activity either genetically 
or pharmacologically reduced cellular senescence and 
downregulated NF-κB activation in cell culture. 
Importantly, Ercc1-/Δ mice heterozygous for Atm 
exhibited significantly reduced NF-κΒ activity, reduced 
cellular senescence, improved muscle-derived 
stem/progenitor cell function and attenuated age-related 
bone and intervertebral disc pathologies, leading to an 
extension of healthspan. Similarly, inhibiting ATM in 
Ercc1-/∆ mice by treatment with the ATM inhibitor KU-
55933 reduced senescence and SASP marker expression. 
These results demonstrate a key role for ATM in aging 
and suggest that it is a therapeutic target for delaying or 
improving numerous age-related diseases. 
 
RESULTS 
 
NF-κB and ATM signaling are highly activated in 
cellular senescence, as well as accelerated and 
natural aging 
 
Our previous studies using transgenic mice carrying a 
NF-κB-dependent EGFP reporter demonstrated an 
increase in the percentage of EGFP-positive cells in the 
liver, kidney, skeletal muscle and pancreas of progeroid 
Ercc1-/Δ and aged wild-type (WT) mice [35]. To further 
quantify NF-κB activation with aging, p-p65 (Ser536), a 
marker of NF-κB activation, was measured in murine 
liver (Figure 1A). Phosphorylation of p65 was 
significantly increased in 16-week-old Ercc1-/Δ mice 
compared to age-matched WT mice (Supplementary 
Figure 1A). In addition, there was an increase in the 
level of p-ATM as well as two senescence markers, 
γH2AX [49] and p21, in Ercc1-/∆ liver compared to WT 
controls (Figure 1B and Supplementary Figure 1B). To 
determine if NF-κB and ATM were activated in WT 
mice with aging, p-p65, p-IκBα and p-ATM were 
measured by immunoblot in liver extracts from WT 
mice at multiple ages. The levels of p-p65 and p-IκBα 
increased gradually with age from 3 to 12 and 24-
months of age (Figure 1C and Supplementary Figure 
1C). These correlated with increased levels of p-ATM 
and the senescence marker p21 at 12 and 24 months of 
age (Figure 1D and Supplementary Figure 1D).  
 
To examine ATM and NF-κΒ activation with 
senescence, the phosphorylation of ATM and NF-κΒ 
targets were measured initially in primary Ercc1-/- 
mouse embryonic fibroblasts (MEFs), which undergo 
premature senescence at 20% O2. The levels of p-ATM 
and p-KAP1 were increased in Ercc1-/- MEFs compared 
to WT MEFs (Figure 1E). Moreover, p-p65 levels were 
increased in passage 5 Ercc1-/- MEFs compared to WT 
cells (Figure 1F). There also was an increase in nuclear 
staining of p65 and NEMO in Ercc1-/- MEFs compared 
to WT cells, indicating NF-κB activation through a 
NEMO-dependent manner (Figure 1G). These findings 
suggest that NF-κB and ATM are co-activated in cells 
and tissues with higher levels of DNA damage-induced 
senescence. 
 
Pharmacologic inhibition of ATM rescues 
senescence caused by genotoxic stress via 
suppressing NEMO-dependent NF-κB activation 
 
To elucidate further the causative role of activated ATM 
and DDR signaling in driving senescence, the effect of a 
selective ATM kinase inhibitor, KU-55933 [50], on 
senescence in MEFs was examined. Treatment of DNA 
repair deficient Ercc1-/- MEFs with KU-55933 (10 μM) 
reduced the percent of SA-βgal positive cells to a level 
similar to WT MEFs (Figure 2A and 2B). Additional 
markers of senescence, including the cell-cycle regulators 
p21Cip1 and p16INK4A, also were decreased by KU-55933 
treatment (Figure 2C). As expected, autophosphorylation 
of ATM at Ser1981 was downregulated by the ATM 
inhibitor, as were the levels of p-KAP1 and γH2AX 
(Figure 2D). Interestingly, ATM inhibition also 
decreased Poly [ADP-ribose] polymerase 1 (PARP1) 
abundance (Figure 2D), an enzyme that promotes DNA 
repair and chromatin remodeling, utilizing NAD+ as a 
cofactor [51]. Interestingly, our results also suggest that 
inhibition of ATM activity may regulate ATM expression 
at protein level as indicated by reduced ATM level 
(Figure 2D). Furthermore, ATM inhibition reduced the 
abundance of nuclear-localized p65 and NEMO and the 
level of p-p65 (Figure 2E), as well as NF-κB 
transcriptional activity, measured using a NF-κB 
luciferase reporter assay (Figure 2F). Finally, treatment 
with the ATM inhibitor significantly reduced expression 
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of multiple senescence and SASP markers as determined 
by qRT-PCR (Figure 2G). Taken together, these results 
suggest that ATM activation triggered by endogenous 
DNA damage plays a critical role in driving cellular 
senescence, SASP and NF-κB activation in a NEMO-
dependent manner.  
Genetic depletion of Atm decreases genotoxic stress-
induced cellular senescence 
 
To eliminate possible off-target effects of the ATM 
inhibitor KU-55933, Ercc1-/- MEFs heterozygous for 
Atm (Ercc1-/-Atm+/-) were generated. The Ercc1-/-Atm+/-
 
 
 
Figure 1. DDR and NF-κB are activated concomitantly in senescent MEFs and aged tissues. (A) Immunoblot detection of p-p65 
and total p65 in liver tissue from 16-week-old WT (n=3) and Ercc1-/Δ (n=3) mice. (B) Immunoblot detection of phosphorylation of ATM and 
downstream targets γH2AX and p21 in liver from 16-week-old WT and Ercc1-/Δ mice. (C) Immunoblot detection of phosphorylation of NF-κB 
and IκBα in liver lysates from 3, 12 and 24 month-old WT mice. n=3 mice per group. (D) Immunoblot detection of p-ATM, ATM and p21 in the 
same liver lysates. (E) Immunoblot detection of DDR effectors in nuclear extracts from passage 5 WT and Ercc1-/- MEFs, grown at 20% oxygen. 
(F) Level of NF-κB activation is higher in Ercc1-/- MEFs compared to WT MEFs at passage 5, as measured by Immunoblot detection of p-p65 
and total p65 in WT and Ercc1-/- MEFs at passage 5 after culturing in 20% oxygen. (G) Representative images of immunofluorescent detection 
of p65 and NEMO in passage 4 WT and Ercc1-/- MEFs grown at 20% oxygen. Blue: DAPI staining; Green: p65 (top panel) or NEMO (bottom 
panel). Images were taken at the magnification of 60x. 
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Figure 2. Pharmacologic inhibition of ATM rescues oxidative stress-induced senescence by suppressing ATM- and NEMO-
mediated NF-κB activation. (A) Representative images of primary WT and Ercc1-/- MEFs were induced to undergo senescence by serial 
passaging at 20% oxygen. At passage 5, MEFs were grown in the presence or absence of KU-55933 (10 μM) for 72 hrs. Senescence was 
determined by SA-βgal staining. Images were obtained at the magnification of 10x. (B) Quantitation of the percent SA-βgal positive cells. 
Graph represents the mean +/- s.e.m. of three independent experiments. Student’s t-test, ***p <0.001, ****p <0.0001. (C) Passage 5 Ercc1-/- 
MEFs treated with vehicle or KU-55933 (10 μM) for 72 hours were collected and levels of p21 and p16INK4a were determined by western 
blotting. (D) Passage 5 Ercc1-/- MEFs were treated with KU-55933 (10 μM) for 72 hours and whole cell lysate (CL) and nuclear extracts (NE) 
were analyzed by immunoblotting for expression of proteins involved in the DNA damage response. (E) Whole cell lysate (CL) and nuclear 
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extract (NE) were extracted from Ercc1-/- MEFs treated with 10 μM of KU-55933 for analysis of nuclear NEMO and p65. GAPDH was used as a 
loading control of total proteins and LaminA/C as a loading control of nuclear protein. (F) Passage 5 WT and Ercc1-/- MEFs transfected with a 
NF-κB-luciferase reporter construct were cultured in the presence or absence of KU-55933 (10 μM) and were collected for luciferase assays 
after 72 hours. (G) qRT-PCR analysis of mRNA expression in passage 5 WT and Ercc1-/- MEFs treated with or without of KU-55933 (10 μM) for 
72 hrs. P values were determined using a Student’s t-test. *p<0.05, **p<0.01, ***p <0.001. 
 
MEFs had increased proliferation compared to Ercc1-/- 
MEFs (Figure 3A). There also was a reduction in the 
percent of SA-ßgal+ Ercc1-/-Atm+/- MEFs compared to 
Ercc1-/- MEFs (Figure 3B and 3C). Expression of p16INK4a 
also was reduced in the double mutant MEFs (Figure 3D). 
Finally, there was a reduction in the level of secreted IL-6, 
a SASP factor, in conditioned media from Ercc1-/-Atm+/- 
MEFs compared to Ercc1-/- cells (Figure 3E). Taken 
together, these results suggest that ATM promotes 
genotoxic stress-induced cellular senescence, in part, 
through the activation NF-κB signaling. 
 
Genetic depletion of Atm extends healthspan in 
Ercc1-/Δ mice by reducing cellular senescence 
 
To determine if Atm heterozygosity extends healthspan 
in Ercc1-/∆ mice, age-related symptoms, including 
kyphosis, tremor, ataxia, gait disorder, hind limb muscle 
wasting, forelimb grip strength and, in particular, 
dystonia were measured weekly in Ercc1-/∆ and Ercc1-
/∆Atm+/- mice. As shown in Figure 4A and 4B, Atm 
heterozygosity reduced the severity and slowed 
progression of aging symptoms in Ercc1-/Δ mice.  
 
To determine if the extended healthspan correlated with 
reduced cellular senescence in Ercc1-/∆Atm+/- mice, the 
levels of expression of senescent markers and SASP 
factors were measured by qRT-PCR analysis. 
Expression of p21 was significantly reduced in 12-week-
old Ercc1-/∆Atm+/- livers compared to those from aged-
matched Ercc1-/∆mice, as was IL-6, a SASP factor and 
NF-κB target gene (Figure 4C). Similarly, the expression 
of senescence markers and SASP factors (except p16) 
were significantly reduced in Ercc1-/∆Atm+/-
 
 
 
Figure 3. Oxidative stress-induced cellular senescence is reduced by genetic depletion of Atm. (A) Proliferation of WT (black), 
Ercc1-/- (blue) and Ercc1-/-Atm+/- (red) MEFs serially passaged at 20% oxygen was measured by an automated cell counter. Data shown are 
representative of three independent experiments using distinct MEF lines. (B) SA-βgal staining of serially passaged MEFs cultured at 20% 
oxygen. Shown are representative images of passage 5 WT, Ercc1-/- and Ercc1-/-Atm+/- MEFs taken at 10x magnification. (C) The average 
percentage of SA-βgal positive cells at each indicated passage. Ten fields were acquired and quantified per sample. Data shown are 
representative of two independent experiments. (D) Senescent WT, Ercc1-/- and Ercc1-/-Atm+/- MEFs (passage 5) cultured at 20% oxygen for 72 
hrs were collected and lysed for immunoblot analysis of p16INK4a. (E) Supernatant collected from senescent WT, Ercc1-/- and Ercc1-/-Atm+/- MEFs 
was analyzed by ELISA for secreted IL-6. Graphs represent mean+/- s.e.m. P value was determined using Student’s t-test. *p<0.05, **p<0.01.  
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quadriceps compared with those in Ercc1-/∆mice (Figure 
4D). In wildtype mice, there was no effect of ATM 
heterozygosity on expression of these senescence and 
SASP markers. Interestingly, IL-6 and TNF-α, but not 
p21Cip1 or p16INK4a expression, were significantly lower 
in liver of 12-week-old Ercc1-/Δ p65+/- mice compared 
to age-matched Ercc1-/ΔAtm+/- mice (Figure 4E). This 
indicates a distinct role for NF-κB in promoting aging. 
Taken together, these results suggest that genetic 
reduction of ATM leads to a reduction in cellular 
senescence and aging symptoms in vivo.  
 
To determine if pharmacologic inhibition of ATM in 
Ercc1-/∆ mice confers a similar reduction in senescence 
and SASP markers as ATM heterozygosity, Ercc1-/∆ 
mice were treated three times per week i.p. for 2 weeks 
with 10 mg/kg of KU-55933. The mice were then 
analyzed for the extent of senescence and SASP in 
different tissues. As shown in Figure 4F, the levels of 
expression of senescent markers and SASP factors were 
measured were significantly reduced in liver tissues 
from Ercc1-/∆ mice compared to untreated controls. 
 
Atm haploinsufficiency improves function of muscle-
derived stem/progenitor cells (MDSPC) 
 
A decline in stem cell function has long been associated 
with aging, which in the musculoskeletal system leads 
to sarcopenia and muscle wasting [1, 52]. We 
previously reported that muscle-derived stem/progenitor 
cells (MDSPCs) isolated from Ercc1-/Δ mice failed to 
proliferate or differentiate properly, similar to MDSCPs 
from naturally aged mice [53]. Interestingly, the 
function of MDSPCs isolated from Ercc1-/∆ mice was 
partially restored by Atm heterozygosity (Figure 5). In 
fact, MDSPCs isolated from Ercc1-/∆Atm+/- mice 
showed similar levels of myogenic differentiation to 
WT mice (Figure 5A, 5C and 5D). Proliferation of 
MDSPCs isolated from Ercc1-/∆Atm+/- mice also 
increased by 50% compared to control MDSPCs 
(Figure 5B). This result is consistent with delayed onset 
and reduced severity of gait disorder observed in Ercc1-
/ΔAtm+/- mice, which is partly due to severe muscle 
wasting (data not shown).  
 
Atm haploinsufficiency improves aging-related 
pathology in certain tissues 
 
To further assess the effect of ATM status on aging, 
tissues from 12-week Ercc1-/∆ and Ercc1-/∆Atm+/- mice 
were examined histologically. There are reduced 
lymphoid aggregates in the liver and kidney of Ercc1-/∆ 
and Ercc1-/∆Atm+/- mice, suggesting reduced 
inflammatory infiltration in tissues at the age analyzed 
[54]. In addition, Ercc1-/∆Atm+/- mice had reduced age-
related bony changes in the lumbar vertebrae, as 
determined using μCT. Compared to WT mice, Ercc1−/∆ 
mice showed marked trabecular bone loss (Figure 6A), 
signified by an increase in osteoporosis (1-BV/TV), a 
decrease in trabecular number (Tb.N) and trabecular 
thickness (Tb.Th) and an increase in the trabecular 
spacing (Tb.Sp). Atm heterozygosity significantly 
improved bone qualities when compared with Ercc1−/∆ 
mice, showing reduced vertebral osteoporosis and 
trabecular spacing, accompanied by a significant 
increase in trabecular number (Figure 6A). However, no 
significant difference was found in trabecular thickness 
(Figure 6A). Ercc1-/∆Atm+/- mice also had improved 
Safranin O staining of the intervertebral disc from the 
lumbar spines, consistent with significantly higher 
levels of glycosaminoglycans (GAGs) in the nucleus 
pulposus (Figure 6B and 6C) [55–57]. GAG 
measurement indicates the level of the matrix 
proteoglycans, which plays a critical role in 
counteracting mechanical forces imparted on the spine 
[58]. Taken together, these results suggest that 
heterozygosity of Atm improves certain age-related 
conditions, in particular in the musculoskeletal system. 
 
Atm haploinsufficiency reduces NF-κB signaling in 
Ercc1-/Δ mice 
 
To determine the extent to which ATM signaling 
mediates NF-κB activation in vivo, livers from 12- and 
16-week-old Ercc1-/Δ and Ercc1-/∆Atm+/- mice were 
examined. There was a significant decrease in DDR 
signaling in Ercc1-/∆Atm+/- mice compared to Ercc1-/Δ 
mice as indicated by reduced levels of p-ATM and 
γH2AX (Figure 7A, 7C and Supplementary Figure 2A, 
2C). Moreover, the levels of p21Cip1 were significantly 
decreased in livers from Ercc1-/∆Atm+/- mice, 
particularly at 12 weeks of age, consistent with reduced 
cellular senescence and the qRT-PCR results (Figure 
4C). Importantly, the level of phospho-p65 was greatly 
reduced in Ercc1-/∆Atm+/- livers (Figure 7B, 7D and 
Supplementary Figure 2B, 2D), suggesting that NF-κB 
activation in Ercc1-/Δ mice is driven, at least in part, by 
ATM activation. Accordingly, there was reduced p-
IκBα and IκBα levels in Ercc1-/∆Atm+/- mice compared 
to Ercc1-/Δ controls (Figure 7B, 7D and Supplementary 
Figure 2B, 2D) [59, 60].  
 
To determine if the molecular changes in Ercc1-/∆Atm+/- 
mice mirror that in Ercc1-/Δp65+/- mice, ATM and NF-
κB activation was measured in Ercc1-/Δ and Ercc1-
/Δp65+/- mice. There was no difference in the level of 
ATM or p-ATM between Ercc1-/Δp65+/- and Ercc1-/Δ 
mice (Figure 7E and Supplementary Figure 2E), 
suggesting that DDR/ATM signaling is the upstream 
regulator of NF-κB. The levels of p-p65 and total IκBα 
were reduced in Ercc1-/Δp65+/- mice compared to Ercc1-
/Δ mice (Figure 7F and Supplementary Figure 2F), 
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Figure 4. Genetic reduction of Atm attenuates aging phenotypes and reduces cellular senescence in vivo. (A) Representative 
images (left panel) of 15-week-old Ercc1-/Δ and Ercc1-/ΔAtm+/- mice illustrating the severity of their dystonia. (B) The composite score of aging 
symptoms (right panel) was plotted at the indicated ages. n=8-10 mice per group. (C) qRT-PCR analysis of mRNA expression in liver from 12-
week-old WT, Atm+/-, Ercc1-/Δ and Ercc1-/ΔAtm+/- mice. n=3-6 per group. (D) qRT-PCR analysis of mRNA expression in quadriceps from 12-
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week-old WT, Atm+/-, Ercc1-/Δ and Ercc1-/ΔAtm+/- mice. n=3-11 per group. (E) qRT-PCR analysis of mRNA expression in liver from 10 to 12-
week-old WT, p65+/-, Ercc1-/Δ and Ercc1-/Δp65+/- mice. n=4-5 per group. (F) mRNA expression of senescence markers in the liver of 12-week-old 
Ercc1-/Δ mice treated with 10 mg/kg of KU-55933 intraperitoneally 3 times per week for two weeks. n = 3 per group. Graphs represent 
mean+/- s.e.m. P value was determined using Student’s t-test. *p<0.05, **p<0.01, ***p <0.001, ****p <0.0001. 
 
consistent with qRT-PCR results (Figure 4E) showing 
reduced NF-κB-mediated transcription. Taken together, 
these results suggest that DDR signaling plays an 
essential role in NF-κB activation in response to 
endogenous DNA damage. Moreover, the deletion of 
one Atm allele is sufficient to attenuate DDR signaling 
and dampen NF-κB activation in vivo.  
 
DISCUSSION 
 
DNA damage is a critical factor in driving cellular 
senescence and aging [61]. Multiple human diseases of 
accelerated aging, such as XFE progeroid syndrome, 
Cockayne syndrome, Hutchinson-Gilford progeria and 
Werner syndrome are caused by inherited defects in 
maintaining genome integrity [48, 62]. Levels of 
oxidative DNA damage are increased in old or progeroid
organisms compared to young [44, 63, 64]. Although the 
ATM kinase is a critical mediator of the DNA damage 
response, in vivo evidence linking chronic activation of 
ATM to senescence and aging is still lacking. Here, we 
demonstrate that ATM activation increases with aging in 
mammals. In addition, in the Ercc1-/∆ progeroid mouse 
model of accelerated aging, genetic reduction of ATM 
reduces cellular senescence, improves stem cell function, 
extends healthspan and reduces certain age-related 
pathologies in the musculoskeletal system. Moreover, we 
demonstrate that ATM promotes senescence and aging, at 
least in part, by regulating the transcriptional activity of 
NF-κB (Figure 8). 
 
ATM activity is increased in liver with aging in not only 
progeroid Ercc1-/Δ mice, but also naturally aged WT 
mice. Similarly, there was an increase in NF-κB activity 
 
 
 
Figure 5. Atm heterozygosity improves muscle stem cell function and muscle regeneration. Myogenic progenitor cells (myoblasts) 
and MDSPCs were isolated via preplate technique, 3 days after myoblasts were obtained, and the bright field pictures were taken. A total of 
three populations of Atm+/-, Ercc1-/∆Atm+/- and Ercc1-/∆ were isolated from distinct mice and tested. All scale bars = 100 µm. (A) MDSPCs were 
cultured in myogenic differentiation medium for 3 days. Bright field images were taken and the cell fusion into multinucleated myotubes was 
determined by immuno-staining for MyHCf, a terminal myogenic differentiation marker. (B) Cell proliferation of MDSPCs was measured using 
an MTS assay. The graph displays the average of three populations. Error bars indicate mean ± SD. ***P<0.001 (C) Representative images of 
immunofluorescence detection of differentiated myofibers. All scale bars in panel C=50 μm. (D) Myogenic differentiation was quantified by 
determining the number of nuclei in MyHCf positive myotubes relative to the total number of nuclei in the culture. Error bars indicate “mean 
±SD”. *P<0.05. **P<0.01. Error bars indicate “mean ± SD”. *P<0.05. Two-tailed Student’s t-test was performed. 
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in livers that correlates with ATM activity. Conversely, 
a reduction in ATM activation in vivo either genetically 
or pharmacologically resulted in a reduction in the 
levels of γH2AX in liver and decreased expression of 
senescent markers and SASP, in particular p21Cip1 and 
Il6 (Figure 4C and 7A, 7C). Consistent with these 
observations, there was an increase in ATM and NF-κB 
activity in ERCC1-deficient cells grown under oxidative 
stress conditions in cell culture. Reduction of ATM 
either genetically or pharmacologically in MEFs also 
resulted in a reduction in oxidative stress-induced 
senescence along with reduction in NF-κB activation. 
 
We previously demonstrated that heterozygosity in 
p65/RelA (Ercc1-/Δp65+/-) in Ercc1-/Δ mice resulted in 
reduced senescence in multiple tissues as well as 
extended healthspan. Here we demonstrate that Atm 
heterozygosity reduced NF-κB activation to an extent 
similar to p65 heterozygosity in Ercc1-/Δ mice, 
suggesting that ATM kinase is a major activator of NF-
κB in the context of DNA-damage mediated senescence 
and aging. As a result, expression of SASP factors 
transcriptionally regulated by NF-κB, especially IL-6, 
was down-regulated in livers of both Ercc1-/Δp65+/- and 
Ercc1-/∆Atm+/- mice. These findings support previous 
studies reporting that ATM activation is indispensable 
for the SASP phenotype secreting inflammatory 
cytokines [46, 65]. Interestingly, p65/RelA 
heterozygosity resulted in a stronger reduction in IL-6 
and TNF-α expression compared to Atm heterozygosity, 
suggesting either an ATM-independent pathway or that 
heterozygosity of Atm has less of an effect on the 
pathway. We speculate that DSBs activate NF-κB 
primarily through an ATM/NEMO-dependent pathway, 
 
 
 
Figure 6. Genetic reduction of Atm improves bone and intervertebral disc pathology in progeroid Ercc1-/Δ mice. (A) 
Representative micro-CT images of lumber spines comparing severity of osteoporosis in 16-week-old WT, Ercc1-/Δ, Ercc1-/ΔAtm+/- mice. n=3-5 
per group. Quantification of vertebral porosity, trabecular number, trabecular separation, thickness of trabecular bone was performed and 
shown. (B) Safranin O staining for disc matrix in thoracic discs from 12-week-old Ercc1-/Δ and Ercc1-/ΔAtm+/- mice. (C) GAG content measured 
by DMMB assays with NP tissues isolated from 12-week-old lumber discs. n=3 each group. Mean+/- s.e.m. P value was determined using 
Student’s t-test. **p<0.01.  
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which then increases the production of TNF-α and other 
SASP factors. These SASP factors, in turn, trigger a 
second wave of NF-κB activation, enhancing cell-
autonomous and cell-non-autonomous senescence  
[30, 66] (Figure 8). Thus, Atm haploinsufficiency only 
dampens the primary activation of NF-κΒ, while p65 
heterozygosity targets both primary and secondary NF-
κB activation, conferring a stronger inhibition of the 
SASP phenotype. These results also are consistent with 
a greater effect of heterozygosity in p65/RelA on liver 
and kidney pathology than Atm heterozygosity.  
 
We previously reported that reduction in p65/RelA in 
muscle derived stem/progenitor cells (MDSPCs) from 
Ercc1-/∆ mice improved their ability to proliferate as 
well as differentiate. Here we demonstrated that 
reduction in ATM activity also improved self-renewal 
and differentiation in muscle derived stem/progenitor 
cells, suggesting persistent activation of ATM-
dependent signaling negatively regulates stem cell 
function (Figure 5). This consistent with the previous 
observation that depletion of p21Cip1, which is regulated 
by ATM-p53, restores stem cell self-renewal and tissue 
homeostasis without accelerating carcinogenesis in 
mice deficient in telomerase [67].  
 
Moreover, we and others previously demonstrated that 
genetic and pharmacological reduction in p65/RelA 
improves bone architecture and reduces osteoporosis [34, 
35]. Here we demonstrated that Atm haploinsufficiency 
also leads to significantly improved osteoporosis and 
reduced disc degeneration (Figure 6), suggesting ATM 
activation could contribute to increased chronic 
inflammation in spines via activating NF-κB in aging.  
 
 
 
Figure 7. ATM and NF-κB activation are downregulated in Ercc1-/Δ mice heterozygous for Atm. (A) Livers were collected at 12 
weeks of age from WT, Ercc1-/Δ and Ercc1-/ΔAtm+/- mic (n=3 per genotype) and lysates analyzed by western blot for activation of ATM and its 
downstream effectors. (B) Same liver lysates were used to measure phosphorylation of p65 and IκBα. (C) Western blot analysis of livers from 
16-week-old WT, Ercc1-/Δ and Ercc1-/ΔAtm+/-mice (n=3 per genotype) probed for activation of ATM. GAPDH was used as a loading control. (D) 
Same liver lysates used to measure activation of NF-κB. (E) Fourteen-week-old livers from Ercc1-/Δ and Ercc1-/Δp65+/- mice (n=3 per genotype) 
were analyzed by western blot for activation of ATM (F) and NF-κB. 
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Persistent DNA damage-mediated DDR signaling, in 
particular ATM activation, has been demonstrated to be 
essential for the establishment of an NF-κB-dependent 
SASP phenotype in cell culture. Nuclear translocation of 
NEMO plays a critical role in relaying nuclear signal to 
cytoplasm to activate NF-κB in response to genotoxic 
stress [28]. For example, increased ATM 
phosphorylation and nuclear-localized NEMO were 
found in the Zmpste24-/- mouse model of Hutchinson-
Gilford progeria syndrome (HGPS), where accumulation 
of nuclear prelamin-A leads to a perturbation of NF-κB 
signaling [34]. The transcription factor GATA4 was 
identified as a key mediator connecting DDR signaling to 
NF-κB activation and the senescent SASP phenotype 
[13]. In addition, ATM/IFI16 mediated non-canonical 
activation of DNA sensing adaptor STING was 
demonstrated recently in etoposide-induced nuclear DNA 
damage, leading to increased NF-κB activation [68]. 
However, in this study, we observed increased nuclear 
localization of NEMO in response to nuclear DNA 
damage, which could be ablated by an ATM inhibitor. 
Thus, our results support the presence of ATM/NEMO-
dependent NF-κB pathway in response to chronic DNA 
damage.  
ATM kinase is best known for its causal role in ataxia 
telangiectasia (AT), a rare autosomal recessive disease 
characterized by progressive neurodegeneration, 
immunodeficiency, cancer predisposition, 
radiosensitivity and premature skin aging [69–71]. 
Despite the fact that Atm-null mice have reduced 
dopaminergic neurons with age, decreased synaptic 
function in hippocampal neurons and defects in neuronal 
network activity, mice heterozygous for Atm improved 
not only neurodegenerative pathology, but also 
Huntington-like behavior in a mouse model of 
Huntington’s disease [22, 72, 73]. In addition, genetic 
and/or pharmacologic reduction of ATM reduced 
doxorubicin-induced cardiotoxicity and rescued cardiac 
inflammation and heart failure caused by DNA single-
strand breaks [74, 75]. These observations are consistent 
with our results showing neurologic symptoms and 
musculoskeletal pathology were improved in Atm 
haploinsufficient Ercc1-/∆ mice. In addition, our study 
showed that a short-term administration of KU55933 
reduced multiple senescence and SASP markers in liver 
tissues in Ercc1-/∆ mice. These results indicate that ATM 
kinase may be a potential drug target for the treatment  
of multiple aging-related diseases, especially those
 
 
 
Figure 8. A model depicting how endogenous nuclear DNA damage activates NF-κB via an ATM- and NEMO-dependent 
mechanism to drive cellular senescence and senescence-associated secretory phenotype (SASP). In response to chronic 
accumulation of endogenous DNA damage, ATM undergoes autophosphorylation and promotes phosphorylation, SUMOylation, and 
monoubiquitylation of NEMO. As a result, monoubiquitylated NEMO along with ATM translocates to the cytoplasm, activating the IKK 
complex. Phosphorylation of IκB leads to the release of p65 so that it can translocate into nucleus upregulating a transcriptional program of 
certain SASP factors, such as TNFα and IL-6. Secreted SASP factors then trigger a second wave of NF-κB activation through cytokine receptors, 
further enhancing cell-autonomous pathway-mediated senescence and inducing non-cell-autonomous pathway-mediated senescence. 
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that have strong correlation with DNA damage 
accumulation. Given that heterozygous carriers of AT are 
symptom-free in general, we speculate that one WT allele 
of Atm is sufficient to exert its function in DNA repair 
and thereby doesn’t trigger the neurological degeneration 
as seen in AT patients. Interestingly, studies in Chinese 
and Italian nonagenarians/centenarians have identified a 
single nucleotide polymorphism (SNP, rs189037) of in 
the promoter region of ATM that moderately represses 
transcription of Atm by regulating its binding to an 
activator protein 2α (AP-2α). These results suggest that, 
similar to our results in Ercc1-/∆ mice, a slight reduction 
in ATM can contribute to extended lifespan in humans 
[76, 77]. 
 
Taken together, our results suggest that ATM acts as the 
main stimulus of NF-κB activation in DNA damaged-
induced senescence and aging. Reduction in ATM 
either genetically or pharmacologically is able to reduce 
the adverse effects of chronic DNA damage, reducing 
cellular senescence, improving stem cell function and 
extending healthpsan. Thus, ATM and NF-κB represent 
therapeutic targets, at least later in life, for improving 
frailty and certain aging-related diseases.  
 
MATERIALS AND METHODS 
 
Cells and mice 
 
Primary mouse embryonic fibroblasts (MEFs) were 
isolated on embryonic day 12.5-13.5. In brief, mouse 
embryos were isolated from yolk sac followed by 
removal of viscera, lung and heart. Embryos were then 
minced into fine chunks, covered with media, cultured 
at 3% oxygen to reduce stresses and serially passaged. 
MEFs were grown in 1:1 of Dulbecco’s Modification of 
Eagles Medium (with 4.5 g/L glucose and L-glutamine) 
and Ham’s F10 medium, supplemented with 10% fetal 
bovine serum, penicillin and streptomycin and non-
essential amino acids. To induce oxidative stress and 
oxidative DNA damage, MEFs were switched to 20% 
oxygen at passage 3. 
 
Ercc1+/- and Ercc1+/Δ mice from C57BL/6J and FVB/NJ 
backgrounds were crossed to generate Ercc1-/Δ F1 
hybrid mice. Atm+/- mice were crossed to Ercc1+/- from 
C57BL/6J background to generate Ercc1+/-Atm+/- mice, 
which were then bred with Ercc1+/Δ mice from FVB/NJ 
background to generate F1 Ercc1-/∆Atm+/- mice. 
Breeders were backcrossed for ten generations yielding 
F1 mice that are genetically identical. Animal protocols 
used in this study were approved by Scripps Florida 
Institutional Animal Care and Use Committee. 
 
12-week-old Ercc1-/Δ mice were injected 
intraperitoneally with 10 mg/kg of KU-55933 (AdooQ 
Bioscience, Irvine, CA, USA) or the same volume of 
vehicle (1% DMSO: 30% PEG400: 69% H2O) 3 times 
per week for two weeks. All mice were euthanized 1 
hour after the last injection. 
 
Immunoblotting 
 
MEFs were treated with either KU-55933 (10 μM, 
Selleckchem) or vehicle for 72 hours prior to harvesting 
for analysis of protein expression. Cell lysates were 
prepared with RIPA buffer (20 mM Tris-HCl (pH 7.5), 
150 mM NaCl, 1 mM Na2EDTA, 1 μM EGTA, 1% NP-
40, 1% sodium deoxycholate, 2.5 μM sodium 
pyrophosphate, 1 μM β-glycerophosphate, 1 μM 
Na3VO4 and 1 µg/ml leupeptin), supplemented with 1X 
of protease inhibitor cocktails (Sigma) and Halt 
phosphatase inhibitor cocktail (Thermo #78420). Snap-
frozen liver and kidney samples were homogenized 
using FastPrep-24 instrument in RIPA buffer. Equal 
amounts of proteins (40 μg) were resolved on 4-15% 
Mini-PROTEAN TGX precast protein gels (Bio-Rad). 
Primary antibodies used are as follows: p-ATM Ser 
1981 (cell lysates: Rockland cat. no. 200-301-400; 
tissue lysates: Santa Cruz sc-47739), ATM (CST 
#2873), p-KAP1 Ser 824(Abcam ab70369), KAP1 
(Abcam ab22553), γ-H2AX (Novus NB100-384), 
PARP1 (CST #9532), p-p65 Ser 536 (CST #3033), p65 
(CST #8242), p-IκBα Ser 32/36 (CST #9246), IκBα 
(Santa Cruz sc-371), p16INK4a (Santa Cruz sc-1207), 
p21Cip1 (Santa Cruz sc-6246), LaminA/C (Santa Cruz 
sc-20681), anti-tubulin (CST #2146), and GAPDH 
(CST #5174). Blots were exposed to X-ray film in a 
dark room or developed on iBright™ FL1000 Imaging 
System (Figure 1E and 1F). Protein levels were 
quantified by Image J software. 
 
Nuclear extraction 
 
Extraction of cytoplasmic and nuclear fractions was 
performed using the NE-PER nuclear and cytoplasmic 
extraction reagents (Thermo Fisher) according to the 
manufacturer’s instructions. Briefly, 1x106 cells were 
suspended and lysed in CERI and CERII reagents 
consecutively on ice to obtain cytoplasmic fractions. 
Pellets of intact nuclei were then suspended in NER 
reagent to release nuclear contents. 
 
NF-κB luciferase reporter assay  
 
Primary MEFs transfected with a NF-κB luciferase 
reporter construct were cultured in 6-well plates in 
triplicate in the absence or presence of KU-55933 (10 
μM) for 72 hrs. Cells were then collected with Passive 
Lysis Buffer (Promega) and luciferase assay (Promega) 
was performed by using a luminometer according to the 
manufacturer’s instructions. 
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Cell proliferation assay 
 
Passage 3 MEFs were seeded at 5x105 cells in 10-cm 
plates, allowed to grow for 72-96 hours to reach 
confluence at 20% oxygen and then trypsinized for 
determination of cell number. Serial passage was 
carried until passage 5 and cell number was determined 
for each passage. Cell number was measured using a 
Moxi Z Mini automated cell counter. Log cell number 
was plotted versus passage number. 
 
Enzyme-linked immunosorbent assay (ELISA) 
 
Supernatant collected at the end of passage 4 from 
primary MEFs was analyzed for IL-6 production by 
ELISA using a mouse IL-6 ELISA kit (Becton 
Dickinson) according to the manufacturer’s instructions. 
 
Quantitative reverse transcription- polymerase 
chain reaction (qRT-PCR) 
 
Snap-frozen tissues were preserved in RNAlater 
stabilization solution (Thermo Fisher). Total RNA was 
extracted using TRIZOL reagent (Life Technologies) 
and 1.5 μg of RNA was subjected to complementary 
DNA (cDNA) synthesis using SuperScript VILO cDNA 
synthesis kit (Thermo Fisher). qRT-PCR was performed 
with Platinum SYBR Green qPCR SuperMix-UDG with 
ROX (Thermo Fisher) in a StepOnePlus Real-Time 
PCR system. Relative expression of target genes was 
calculated using the comparative CT method (ΔΔCT). 
ΔCT was calculated by normalizing to an internal 
control gene Actb (β-actin) and ΔΔCT by normalizing to 
the mean ΔCT value of the control group. Primers used 
are as follows: Cdkn1a (p21Cip1) forward: 
GTCAGGCTGGTCTGCCTCCG; Cdkn1a (p21Cip1) 
reverse: CGGTCCCGTGGACAGTGAGCAG; Cdkn2a 
(p16INK4a) forward: CCCAACGCCCCGAACT; Cdkn2a 
(p16INK4a) reverse: GCAGAAGAGCTGCTACGTGAA; 
Tnf (TNF) forward: CTATGTCTCAGCCTCTTCTC; 
Tnf (TNF) reverse: CATTTGGGAACTTCTCATCC; 
Il6 (IL-6) forward: AAGAAATGATGGATGCTACC; 
Il6 (IL-6) reverse: GAGTTTCTGTATCTCTCTGAAG; 
IL-1α forward: ACGGCTGAGTTTCAGTGAGACC; 
IL-1α reverse: CACTCTGGTAGGTGTAAGGTGC; 
IL-1β forward: TGGACCTTCCAGGATGAGGACA; 
IL-1β reverse: GTTCATCTCGGAGCCTGTAGTG; 
Mcp-1 forward: GCTACAAGAGGATCACCAGCAG; 
Mcp-1 reverse: GTCTGGACCCATTCCTTCTTGG; 
Pai-1 forward: CCTCTTCCACAAGTCTGATGGC; 
Pai-1 reverse: GCAGTTCCACAACGTCATACTCG; 
Cxcl-1 forward: TCCAGAGCTTGAAGGTGTTGCC; 
Cxcl-1 reverse: AACCAAGGGAGCTTCAGGGTCA; 
Cxcl-2 forward: CATCCAGAGCTTGAGTGTGACG; 
Cxcl-2 reverse: GGCTTCAGGGTCAAGGCAAACT; 
COX2 forward: GCGACATACTCAAGCAGGAGCA; 
COX2 reverse: AGTGGTAACCGCTCAGGTGTTG; 
iNOS forward: GAGACAGGGAAGTCTGAAGCAC; 
iNOS reverse: CCAGCAGTAGTTGCTCCTCTTC; p53 
forward: CTCTCCCCCGCAAAAGAAAAA; p53 
reverse: CGGAACATCTCGAAGCGTTTA; p19 
forward: GGAGCTGGTGCATCCTGACGC; p19 
reverse: TGGCACCTTGCTTCAGGAGCTC; Mmp3 
forward: CTCTGGAACCTGAGACATCACC; Mmp3 
reverse: AGGAGTCCTGAGAGATTTGCGC; Mmp12 
forward: CACACTTCCCAGGAATCAAGCC; Mmp12 
reverse: TTTGGTGACACGACGGAACAGG; Actb (β-
actin) forward: GATGTATGAAGGCTTTGGTC; Actb 
(β-actin) reverse: TGTGCACTTTTATTGGTCTC. 
 
Immunofluorescent staining 
 
Primary MEFs were seeded into 8-well chamber slides 
and allowed to attach overnight at 20% oxygen. Cells 
were then fixed with 4% paraformaldehyde (PFA) for 
10 min, permeabilized with 0.3% Triton X-100 in PBS 
for 10 min and blocked with 3% BSA in PBST for 1 hr 
in room temperature. Primary antibody incubation was 
performed at 4°C overnight and secondary antibody 
incubation for 1 hr at room temperature. Primary 
antibodies used are as follows: anti-p65 (CST #8242) 
and anti-NEMO (Santa Cruz sc-8330). Cell nuclei were 
counterstained with Vectashield mounting medium with 
DAPI. Five images were acquired for each sample at 
60x magnification using an Olympus confocal 
microscopy.  
 
Senescence-associated β-galactosidase (SA-βgal) 
staining in vitro and in vivo  
 
Primary MEFs were seeded into 6-well plates at 3x104 
cells per well, allowed to attach overnight and then 
treated with either vehicle or KU-55933 at 10 μM for 72 
hours. Fresh fat tissues were preserved in ice-cold PBS 
prior to staining. MEFs and adipose tissues were then 
fixed in 2% formaldehyde and 0.2% glutaraldehyde in 
PBS for 10 minutes followed by incubation with SA-
βgal staining solution (MEFs: pH 5.8; Fat: pH 6.0; 40 
μM citric acid in sodium phosphate buffer, 5 μM 
K4[Fe(CN)6] 3H2O, 5 μM K3[Fe(CN)6], 150 μM sodium 
chloride, 2 μM magnesium chloride and 1 mg/ml X-gal 
dissolved in N, N-dimethylformamide) for 16-20 hours 
in a 37°C incubator without CO2 injector. To quantify, 
ten images were acquired randomly using a bright-field 
microscopy at 20x maginification. Total number of SA-
βgal+ cells was normalized to the total cell number 
(DAPI) to obtain the percentage of SA-βgal+ cells.  
 
Health evaluation  
 
Health assessments were conducted weekly to assess 
the age at onset and severity of numerous age-related 
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conditions characteristic of Ercc1-/∆ mice, including 
dystonia, ataxia, kyphosis, tremor, muscle wasting, 
spontaneous activity and coat condition. In addition, 
body weight and grip strength were measured. All aging 
symptoms were scored on a scale of 0, 0.5 and 1, except 
for dystonia on a scale from 0 to 5. The sum of aging 
scores was used to determine the overall health of the 
individual animals, then averaged by genotype and age 
group. 
 
MDSPC isolation 
 
The Atm+/-, Ercc1-/∆Atm+/- and Ercc1-/∆ mice were 
sacrificed at 16 to 18 weeks of age, and MDSPC 
isolation was performed via a modified preplate 
technique as previously described [78, 79]. Briefly, the 
skeletal muscle tissue was minced and processed 
through a series of enzymatic dissociations: 0.2% of 
collagenase type XI (C7657, Sigma-Aldrich) for 1 hour, 
2.4 units/ml of dispase (17105-041, Invitrogen) for 45 
minutes, and 0.1% of trypsin-EDTA (15400-054, 
Invitrogen) for 30 minutes at 37°C. After enzymatic 
dissociation, the muscle cells were centrifuged and 
resuspended in proliferation medium (Dulbecco’s 
modified Eagle’s medium (DMEM, 11995-073, 
Invitrogen) supplemented with 10% fetal bovine serum 
(FBS, 10437-028, Invitrogen), 10% horse serum (HS, 
26050-088, Invitrogen), 0.5% chicken embryo extract 
(CEE, CE650T-10, Accurate Chemical Co.), and 1% 
penicillin-streptomycin (15140-122, Invitrogen). The 
cells were then plated on collagen type I (C9791, 
Sigma-Aldrich) coated flasks. Different populations of 
muscle-derived cells were isolated based on their 
different adhesion characteristics. After 7 days, late 
preplate populations (slow-adhering cells), which have 
previously been described to contain the MDSPC 
fraction of cells, were obtained and cultured in 
proliferation medium [80].  
 
MDSPC proliferation assay 
 
MDSPCs were cultured at 5,000 cells per well in 
collagen-coated 24-well plates in proliferation medium. 
Cell proliferation was tested with an MTS assay. After 3 
days, proliferation medium was removed from wells 
and 100 µl of fresh proliferation medium was added to 
each well and allowed to equilibrate for 1 hr. Then, 20 
µl of MTS reagent (Promega, Cat# G3582) was added 
to each well and incubated for 4 hrs. The optical density 
at 490 nm was measured using a spectrophotometer.  
 
Myogenic differentiation assay and fast myosin 
heavy chain staining 
 
The cells were plated on 24 well plates (30,000 cells/well) 
in differentiation medium (DMEM supplemented with 2% 
FBS). Three days after plating, immunocytochemical 
staining for fast myosin heavy chain (MyHCf) was 
performed. Cells were fixed for 2 minutes in cold 
methanol (-20°C), blocked with 10% donkey serum (017-
000-121, Jackson ImmunoResearch) for 1 hour and then 
incubated with a mouse anti-MyHCf (M4276, 1:250; 
Sigma-Aldrich) antibody for 2 hours at RT. The primary 
antibody was detected with an Alexa 594-conjugated 
anti-mouse IgG antibody (A21203, 1:500; Molecular 
probes) for 30 minutes. The nuclei were revealed by 4, 6-
diamidino-2- phenylindole (DAPI, D9542, 100ng/ml, 
Sigma-Aldrich) staining. The percentage of differentiated 
myotubes was quantified as the number of nuclei in 
MyHCf positive myotubes relative to the total number of 
nuclei.  
 
Histologic analysis 
 
Tissues were fixed in 10% neutral buffered formalin 
(NBF) overnight before embedding in paraffin. 5 μm 
sections were acquired using a microtome. Hematoxylin 
and eosin (H&E) staining was conducted following a 
standard protocol. 
 
Glycosaminoglycan (GAG) analysis  
 
Snap frozen lumber spines were harvested at 12 weeks 
of age from Ercc1-/Δ and Ercc1-/∆Atm+/- mice. Nucleus 
pulposus (NP) tissue was isolated and dissected under a 
microscope and six lumbar intervertebral discs were 
pooled for analysis. GAG was isolated by papain 
digestion at 60°C for 2 hrs. Concentration of GAG was 
measured according to the 1,9-dimethymethylene blue 
(DMMB) procedure using chondroitin-6-sulfate (Sigma 
C-8529) as the standard. DNA concentration was 
measured using Pico Green assay (Molecular Probes). 
Fold change of GAG content was calculated by 
normalizing GAG to DNA concentration. 
 
Micro-computed tomography 
 
Micro-computed tomography (μCT) of spines isolated 
from 12-week-old wild type (WT), Ercc1–/Δ and Ercc1–
/ΔAtm+/- mouse littermates were acquired using the 
VivaCT 40 scanner (Scanco, Switzerland) with settings: 
energy 55 kvP, intensity 145 μA, integration time 
200ms, isotropic voxel size 15 μm, threshold 235. 3D 
morphometric analysis were performed on lumbar 
vertebrae segments (L3-S1). 
 
Statistical analysis 
 
All values were presented as mean+/-S.E.M. Microsoft 
Excel and Graphpad Prism 6 were used for statistical 
analysis. Two-tailed Student’s t-test was performed to 
determine differences between two groups. A value of p 
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<0.05 was considered as statistically significant, shown 
as *p <0.05, **p <0.01, and ***p < 0.001. 
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SUPPLEMENTARY MATERIALS 
 
Supplementary Figures 
 
 
 
 
Supplementary Figure 1. DDR and NF-κB are activated in tissues from progeroid Ercc1-/Δ and old WT mice. Densitometric 
analysis of Western Blot shown in Figure 1A (A), Figure 1B (B), Figure 1C. (C) and Figure 1D (D). (A–B) Two-tailed Student’s t-test was 
performed. (C–D) One-way ANOVA was performed. *p <0.05, **p <0.01 or as indicated in the figure. 
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Supplementary Figure 2. Atm haploinsufficiency reduces senescence by regulating NF-κB activation. Densitometric analysis of 
Western Blot shown in Figure 7A (A), Figure 7B (B), Figure 7C (C), Figure 7D (D), Figure 7E (E) and Figure 7F (F). P values were determined 
using a Student’s t-test. *p <0.05, **p <0.01, ***p<0.001 or as indicated in the figure. 
  
 www.aging-us.com 4710 AGING 
 
 
Supplementary Figure 3. Genetic reduction or pharmacologic inhibition of Atm or NF-κB attenuates aging phenotypes and 
reduces cellular senescence in vivo. (A) qRT-PCR analysis of mRNA expression in liver from 12-week-old WT, Atm+/-, Ercc1-/Δ and Ercc1-
/ΔAtm+/- mice. n=3-6 per group. (B) qRT-PCR analysis of mRNA expression in liver from 10 to 12-week-old WT, p65+/-, Ercc1-/Δ and Ercc1-/Δp65+/- 
mice. n=4-5 per group. (C) mRNA expression of senescence markers in the kidney of 12-week-old Ercc1-/Δ mice treated with 10 mg/kg of KU-
55933 intraperitoneally 3 times per week for two weeks. n = 3 per group. Graphs represent mean+/- s.e.m. P value was determined using 
Student’s t-test. *p<0.05, **p<0.01, ***p <0.001, ****p <0.0001. 
